SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-102815
Filing Date
2005-05-10
Accepted
2005-05-10 16:24:24
Documents
10
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2005 d10q.htm 10-Q 179032
2 CO-PROMOTION AGREEMENT dex1050.htm EX-10.50 181405
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9964
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9857
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2660
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2752
7 GRAPHIC g45492image001.jpg GRAPHIC 101126
8 GRAPHIC g45492image002.jpg GRAPHIC 31144
9 GRAPHIC g45492image003.jpg GRAPHIC 34959
10 GRAPHIC g45492image004.jpg GRAPHIC 127106
  Complete submission text file 0001193125-05-102815.txt   793308
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 05817049
SIC: 2834 Pharmaceutical Preparations